These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11594527)

  • 1. Severe autoimmune thrombocytopenia after allogeneic bone marrow transplantation for aplastic anemia.
    Tomonari A; Tojo A; Lseki T; Ooi J; Nagayama H; Ogami K; Maekawa T; Shirafuji N; Tani K; Asano S
    Int J Hematol; 2001 Aug; 74(2):228-32. PubMed ID: 11594527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunological syndrome featuring transverse myelitis, Evans syndrome and pulmonary infiltrates after unrelated bone marrow transplant in a patient with severe aplastic anemia.
    Richard S; Fruchtman S; Scigliano E; Skerrett D; Najfeld V; Isola L
    Bone Marrow Transplant; 2000 Dec; 26(11):1225-8. PubMed ID: 11149736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful bone marrow transplantation in children with severe aplastic anemia using HLA-partially matched family donors.
    Locatelli F; Porta F; Zecca M; Pedrazzoli P; Maccario R; Giani S; Vitale V; Martinetti M; Mazzolari E; Lanfranchi A
    Am J Hematol; 1993 Mar; 42(3):328-33. PubMed ID: 8438907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation.
    Min CK; Kim DW; Lee JW; Min WS; Kim CC
    Acta Haematol; 2000; 104(4):185-92. PubMed ID: 11279309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons between allogeneic peripheral blood stem cell transplantation and allogeneic bone marrow transplantation in adult hematologic disease: a single center experience.
    Liu YC; Chang CS; Liu TC; Chen TP; Sue YC; Hsiao HH; Lin SF
    Kaohsiung J Med Sci; 2003 Nov; 19(11):541-8. PubMed ID: 14658482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired autoimmune thrombocytopenia post-bone marrow transplantation for severe combined immunodeficiency.
    Ting SS; Ziegler JB; Vowels MR
    Bone Marrow Transplant; 1998 Apr; 21(8):841-3. PubMed ID: 9603413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
    Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R
    Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of chronic graft-versus-host-disease following allogeneic peripheral blood stem cell rescue for poor graft function after bone marrow transplantation.
    Kim HJ; Chung IJ; Lee JJ; Seo JS; Park MR; Choi KS; Kook H; Hwang TJ
    Korean J Intern Med; 1998 Feb; 13(1):60-3. PubMed ID: 9538634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia.
    Reiter E; Keil F; Brugger S; Kalhs P; Rabitsch W; Hinterberger W; Fischer G; Rosenmayr A; Haas O; Volc B; Lechner K; Greinix HT
    Bone Marrow Transplant; 1997 Jun; 19(12):1191-6. PubMed ID: 9208112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation.
    Trede NS; Warwick AB; Rosoff PM; Rohrer R; Bierer BE; Guinan E
    Bone Marrow Transplant; 1997 Aug; 20(3):257-60. PubMed ID: 9257897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Graves-Basedow disease after allogeneic bone marrow transplantation].
    Jakubas B; Kostecka-Matyja M; Darczuk A; Gil J
    Endokrynol Pol; 2006; 57(5):541-3. PubMed ID: 17133320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic peripheral blood stem cell rescue of late graft failure after bone marrow transplantation in patients with aplastic anemia.
    Chung IJ; Lee JJ; Park MR; Kook H; Cho SH; Hwang TJ; Kim HJ
    J Korean Med Sci; 2002 Aug; 17(4):468-74. PubMed ID: 12172040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
    van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM
    Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marrow transplant experience for children with severe aplastic anemia.
    Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience.
    Hernández-Boluda JC; Marín P; Carreras E; Aguilar JL; Grañena A; Rozman C; Montserrat E
    Haematologica; 1999 Jan; 84(1):26-31. PubMed ID: 10091390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation.
    Yabe M; Yabe H; Hattori K; Morimoto T; Hinohara T; Takakura I; Shimizu T; Shimamura K; Tang X; Kato S
    Bone Marrow Transplant; 1997 Feb; 19(4):389-92. PubMed ID: 9051251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation for fourteen patients with severe aplastic anemia.
    Hsueh EJ; Hwang WS; Huang SH; Chao TY; Chang JY; Wang CC
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Apr; 57(4):247-53. PubMed ID: 8705875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.